PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CLBT vs. PLTR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CLBT and PLTR is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

CLBT vs. PLTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cellebrite DI Ltd. (CLBT) and Palantir Technologies Inc. (PLTR). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%150.00%200.00%250.00%300.00%SeptemberOctoberNovemberDecember2025February
20.92%
285.59%
CLBT
PLTR

Key characteristics

Sharpe Ratio

CLBT:

2.65

PLTR:

6.31

Sortino Ratio

CLBT:

3.28

PLTR:

5.70

Omega Ratio

CLBT:

1.44

PLTR:

1.75

Calmar Ratio

CLBT:

4.99

PLTR:

8.31

Martin Ratio

CLBT:

17.10

PLTR:

42.23

Ulcer Index

CLBT:

6.41%

PLTR:

9.35%

Daily Std Dev

CLBT:

39.67%

PLTR:

62.61%

Max Drawdown

CLBT:

-67.74%

PLTR:

-84.62%

Current Drawdown

CLBT:

-21.96%

PLTR:

0.00%

Fundamentals

Market Cap

CLBT:

$4.36B

PLTR:

$292.28B

EPS

CLBT:

-$1.35

PLTR:

$0.19

Total Revenue (TTM)

CLBT:

$309.43M

PLTR:

$2.87B

Gross Profit (TTM)

CLBT:

$262.28M

PLTR:

$2.30B

EBITDA (TTM)

CLBT:

-$165.00M

PLTR:

$334.98M

Returns By Period

In the year-to-date period, CLBT achieves a -7.90% return, which is significantly lower than PLTR's 64.78% return.


CLBT

YTD

-7.90%

1M

-10.93%

6M

20.92%

1Y

78.14%

5Y*

N/A

10Y*

N/A

PLTR

YTD

64.78%

1M

73.64%

6M

285.58%

1Y

409.90%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CLBT vs. PLTR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLBT
The Risk-Adjusted Performance Rank of CLBT is 9595
Overall Rank
The Sharpe Ratio Rank of CLBT is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of CLBT is 9393
Sortino Ratio Rank
The Omega Ratio Rank of CLBT is 9292
Omega Ratio Rank
The Calmar Ratio Rank of CLBT is 9898
Calmar Ratio Rank
The Martin Ratio Rank of CLBT is 9696
Martin Ratio Rank

PLTR
The Risk-Adjusted Performance Rank of PLTR is 9999
Overall Rank
The Sharpe Ratio Rank of PLTR is 100100
Sharpe Ratio Rank
The Sortino Ratio Rank of PLTR is 9999
Sortino Ratio Rank
The Omega Ratio Rank of PLTR is 9898
Omega Ratio Rank
The Calmar Ratio Rank of PLTR is 9999
Calmar Ratio Rank
The Martin Ratio Rank of PLTR is 9999
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CLBT vs. PLTR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cellebrite DI Ltd. (CLBT) and Palantir Technologies Inc. (PLTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CLBT, currently valued at 2.65, compared to the broader market-2.000.002.004.002.656.31
The chart of Sortino ratio for CLBT, currently valued at 3.28, compared to the broader market-6.00-4.00-2.000.002.004.006.003.285.70
The chart of Omega ratio for CLBT, currently valued at 1.44, compared to the broader market0.501.001.502.001.441.75
The chart of Calmar ratio for CLBT, currently valued at 4.99, compared to the broader market0.002.004.006.004.9913.68
The chart of Martin ratio for CLBT, currently valued at 17.10, compared to the broader market0.0010.0020.0030.0017.1042.23
CLBT
PLTR

The current CLBT Sharpe Ratio is 2.65, which is lower than the PLTR Sharpe Ratio of 6.31. The chart below compares the historical Sharpe Ratios of CLBT and PLTR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio2.004.006.008.00SeptemberOctoberNovemberDecember2025February
2.65
6.31
CLBT
PLTR

Dividends

CLBT vs. PLTR - Dividend Comparison

Neither CLBT nor PLTR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CLBT vs. PLTR - Drawdown Comparison

The maximum CLBT drawdown since its inception was -67.74%, smaller than the maximum PLTR drawdown of -84.62%. Use the drawdown chart below to compare losses from any high point for CLBT and PLTR. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-21.96%
0
CLBT
PLTR

Volatility

CLBT vs. PLTR - Volatility Comparison

The current volatility for Cellebrite DI Ltd. (CLBT) is 18.77%, while Palantir Technologies Inc. (PLTR) has a volatility of 24.77%. This indicates that CLBT experiences smaller price fluctuations and is considered to be less risky than PLTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
18.77%
24.77%
CLBT
PLTR

Financials

CLBT vs. PLTR - Financials Comparison

This section allows you to compare key financial metrics between Cellebrite DI Ltd. and Palantir Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab